| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ANGEL2 | BEND7 | ENSOCUP00000007418 | ENSOCUP00000003929 | Angel homolog 2. | BEN domain containing 7. | 0.556 |
| ANGEL2 | SHLD1 | ENSOCUP00000007418 | ENSOCUP00000008036 | Angel homolog 2. | Shieldin complex subunit 1. | 0.527 |
| BEND7 | ANGEL2 | ENSOCUP00000003929 | ENSOCUP00000007418 | BEN domain containing 7. | Angel homolog 2. | 0.556 |
| BEND7 | SHLD1 | ENSOCUP00000003929 | ENSOCUP00000008036 | BEN domain containing 7. | Shieldin complex subunit 1. | 0.504 |
| BRCA1 | CTC1 | ENSOCUP00000003366 | ENSOCUP00000035742 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | CST telomere replication complex component 1. | 0.614 |
| BRCA1 | LIG4 | ENSOCUP00000003366 | ENSOCUP00000013516 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | DNA ligase. | 0.907 |
| BRCA1 | MAD2L2 | ENSOCUP00000003366 | ENSOCUP00000036253 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Mitotic arrest deficient 2 like 2. | 0.766 |
| BRCA1 | POLQ | ENSOCUP00000003366 | ENSOCUP00000006990 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | DNA polymerase theta. | 0.764 |
| BRCA1 | RIF1 | ENSOCUP00000003366 | ENSOCUP00000022283 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Replication timing regulatory factor 1. | 0.808 |
| BRCA1 | SHLD1 | ENSOCUP00000003366 | ENSOCUP00000008036 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Shieldin complex subunit 1. | 0.520 |
| BRCA1 | SHLD2 | ENSOCUP00000003366 | ENSOCUP00000003791 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Shieldin complex subunit 2. | 0.641 |
| CTC1 | BRCA1 | ENSOCUP00000035742 | ENSOCUP00000003366 | CST telomere replication complex component 1. | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | 0.614 |
| CTC1 | LIG4 | ENSOCUP00000035742 | ENSOCUP00000013516 | CST telomere replication complex component 1. | DNA ligase. | 0.464 |
| CTC1 | MAD2L2 | ENSOCUP00000035742 | ENSOCUP00000036253 | CST telomere replication complex component 1. | Mitotic arrest deficient 2 like 2. | 0.430 |
| CTC1 | POLQ | ENSOCUP00000035742 | ENSOCUP00000006990 | CST telomere replication complex component 1. | DNA polymerase theta. | 0.413 |
| CTC1 | SHLD1 | ENSOCUP00000035742 | ENSOCUP00000008036 | CST telomere replication complex component 1. | Shieldin complex subunit 1. | 0.890 |
| CTC1 | SHLD2 | ENSOCUP00000035742 | ENSOCUP00000003791 | CST telomere replication complex component 1. | Shieldin complex subunit 2. | 0.876 |
| ERCC6L2 | LIG4 | ENSOCUP00000000394 | ENSOCUP00000013516 | Uncharacterized protein. | DNA ligase. | 0.609 |
| ERCC6L2 | MAD2L2 | ENSOCUP00000000394 | ENSOCUP00000036253 | Uncharacterized protein. | Mitotic arrest deficient 2 like 2. | 0.400 |
| ERCC6L2 | SHLD1 | ENSOCUP00000000394 | ENSOCUP00000008036 | Uncharacterized protein. | Shieldin complex subunit 1. | 0.588 |
